Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.
P3 Health Partners Inc. reports developments in population health management, value-based primary care and physician-led care coordination. The company supports community providers through administrative services, clinical operations, data-driven care enablement and partnerships tied to Medicare Advantage, accountable care organizations and delegated-risk arrangements.
Recurring updates include quarterly results, guidance, revenue trends, capitated revenue per member, medical margin, adjusted EBITDA and operating changes in the Care Enablement Model. Company news also covers payer and provider agreements, ACO management services, market expansion, investor conference participation and joint venture activity such as the P3 Commonwealth Innovation MSO.
P3 Health Partners (NASDAQ: PIII) reported Q2 2025 financial results, demonstrating resilience in its core business despite industry challenges. The company achieved flat medical cost trends and recorded total revenue of $355.8 million, down 6% year-over-year. Average at-risk membership decreased 9% to 115,000 members due to network rationalization.
The company's medical margin was $30.6 million ($89 PMPM), while adjusted EBITDA showed a loss of $17.1 million ($50 PMPM). Notably, P3 has identified $120-$170 million in additional EBITDA opportunities for 2026. The company revised its FY2025 guidance, projecting total revenues between $1.35-$1.5 billion and adjusted EBITDA loss between $69-39 million.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has scheduled its second quarter 2025 earnings release and conference call for August 14, 2025.
The company will release its Q2 2025 financial results and file its Form 10-Q on the same day. Management will host a conference call at 4:30 PM ET to discuss the results. Investors can access the call via toll-free number 1-833-316-0546 (US) or 1-412-317-0692 (International).
A live webcast will be available in the "Events & Presentations" section of P3's investor relations website. An archived recording will remain accessible for 90 days following the call.
P3 Health Partners (NASDAQ: PIII) has announced it will release its first quarter 2025 financial results and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. The company will host a conference call with management to discuss the results at 4:30 PM ET/1:30 PM PT on the same day.
Investors can join the conference call through the toll-free number 1-833-316-0546 (US) or internationally at 1-412-317-0692. A live webcast will be available in the "Events & Presentations" section of P3's investor relations website. The webcast recording will remain accessible on the company's website for 90 days following the call.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management team is scheduled to deliver a presentation on Thursday, April 10, 2025, at 9:45 AM Pacific Time.
Investors and interested parties can access the presentation through a webcast available on P3's Investor Relations Website at ir.p3hp.org. The presentation recording will remain accessible on the company's investor relations webpage for 30 days following the event.
P3 Health Partners (NASDAQ: PIII) reported its Q4 and full-year 2024 financial results, showing mixed performance. Full-year revenue reached $1.50 billion, up 18% year-over-year, with capitated revenue increasing 18% to $1.48 billion.
The company's at-risk membership grew 14% to 123,800 members. However, financial metrics showed significant challenges: Full-year net loss widened to $310.4 million from $186.4 million, while medical margin decreased 37% to $85.5 million. Q4 2024 results included total revenue of $370.7 million (up 7%) but showed a gross profit loss of $39.5 million.
CEO Aric Coffman highlighted the company's fundamentally strong business model and identified $130M+ in programmatic opportunities to improve financial sustainability.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced it will release its fourth quarter and full year 2024 financial results on March 27, 2025. The company will host a conference call with management to discuss the results at 1:30 PM PT/4:30 PM ET on the same day.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, will participate in the TD Cowen 45th Annual Health Care Conference in Boston, Massachusetts.
Management is scheduled to host investor meetings on Wednesday, March 5th, 2025.
P3 Health Partners (NASDAQ: PIII) has announced preliminary guidance for 2025 and a proposed financing transaction. The company targets profitability in 2025 with projected revenues between $1.350 billion and $1.500 billion and Adjusted EBITDA ranging from negative $35 million to positive $5 million. CEO Aric Coffman noted that the company is on track with its $130+ million EBITDA growth initiatives and expects to issue full 2025 guidance with Q4 2024 earnings.
P3 is in discussions for a $30 million unsecured promissory note and warrants, similar to a December 2024 transaction. This financing is subject to approval by independent directors and final documentation. The guidance includes an estimated 108,000 to 118,000 at-risk members by the end of 2025. The company emphasizes that these projections are subject to change based on various factors, and no obligation to update estimates is assumed.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The company's management will deliver a presentation on Tuesday, January 14, 2024, at 7:30 AM Pacific Time. A webcast of the presentation will be accessible on P3’s Investor Relations Website at https://ir.p3hp.org/. Additionally, a replay of the presentation will be available on the same webpage for 30 days following the event.